Plasma endothelin-1 concentrations in patients with retinal vein occlusions

British Journal of Ophthalmology

Volumn 82, Issue 5, 1998, Pages 498-503

  Iannaccone, Alessandro ^a,b   Letizia, Claudio ^a   Pazzaglia, Sebastiano ^a   Vingolo, Enzo M ^a   Clemente, Giovanni ^a   Pannarale, Mario R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HOMEOSTASIS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETINA BLOOD FLOW; RETINA VEIN OCCLUSION;

EID: 0031749420     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.5.498     Document Type: Article

References (50)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature 1988;332:411-5.
2. Martin ER, Brenner BM, Ballerman BJ. Heterogeneity of cell surface endothelin receptors. J Cell Biol Chem 1990;265:14044-9.
3. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203-8.
4. Chakravarthy U, Douglas AJ, Bailie JR, et al. Immunoreactive endothelin distribution in ocular tissues. Invest Ophthalmol Vis Sci 1994;35:2448-54.
5. McCumber MW, D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol 1994;112:1231-5.
6. B) receptors in cultured bovine retinal pericytes. Invest Ophthalmol Vis Sci 1995;36:1088-94.
7. Sakaue H, Kiryu J, Takeuchi A, et al. Effects of endothelin on retinal blood vessels. Acta Soc Ophthalmol Jpn 1992;96: 469-72.
8. Meyer P, Flammer J, Lüscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci 1993;34:3614-21.
9. Ramachadran E, Frank RN, Kennedy A. Effects of endothelin on cultured bovine retinal microvascular pericytes. Invest Ophthalmol Vis Sci 1993;34:586-95.
10. Chakravarthy U, Gardiner TA, Anderson P, et al. The effect of endothelin 1 on the retinal microvascular pericyte. Microvasc Res 1992;43:241-54.
11. Pannarale L, Onori P, Ripani M, et al. Retinal microcirculation as revealed by SEM corrosion casts in the rat. Eur J Ophthalmol 1991;1:96-102.
12. Pannarale L, Onori P, Gaudio E, et al. Precapillary vessels and preferential channels in rat retina microvasculature. A comparative analysis of corrosion casts and digested tissue specimens by scanning electron microscopy. (ARVO abstract) Invest Ophthalmol Vis Sci 1992;33 (4 suppl):809.
13. Gaudio E, Onori P, Ripani M, et al. Smooth muscle cells and pericytes arrangement can contribute to preferential blood flow in retinal microvasculature. (ARVO abstracts) Invest Ophthalmol Vis Sci 1993;34 (4 suppl):1397.
14. Orlidge A, D'Amore PA. Inhibition of capillary endothelial growth by pericytes and smooth muscle cells. J Cell Biol 1987;105:1455-62.
15. Capetandes A, Gerritsen ME. Heterogeneity in retinal microvascular endothelial cell growth control by pericytes. In: Weinreb RN, Joiner WL, Wheeler LA, eds. Biology of the ocular microcirculation. International Congress Series 993. Amsterdam: Excerpta Medica, Elsevier Science Publishers, 1992:81-90.
16. Haefliger IO, Flammer J, Lüscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 1992;33:2340-3.
17. Brown SM, Jampol LM. New concepts of regulation of retinal vessel tone. Arch Ophthalmol 1996;114:199-204.
18. Ye X, Laties AM, Stone RA. Peptidergic innervation of the retinal vasculature and optic nerve head. Invest Ophthalmol Vis Sci 1990;31:1731-7.
19. Granstam E, Wang L, Bill A. Ocular effects of endothelin-1 in the cat. Curr Eye Res 1992;11:325-32.
20. Takei K, Sato T, Nonoyama T, et al. A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits. Graefes Arch Clin Exp Ophthalmol 1993;231:476-81.
21. Bursell S-E, Clermont AC, Oren B, et al. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 1995;36:596-607.
22. Takagi C, Bursell S-E, Lin Y-W, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 1996;37: 2504-18.
23. Chakravarthy U, Hayes RG, Stitt AW, et al. Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci 1997;38:2144-2151.
24. Williamson TH. Central retinal vein occlusion: what's the story? Br J Ophthalmol 1997;81:698-704.
25. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145:574-84.
26. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
27. Lutty GA, McLeod DS, Merges C, et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996;114:971-7.
28. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
29. Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997;276:1706-9.
30. Rodeheffer R, Lerman A, Heublein DH, et al. Plasma endothelin concentrations are increased in humans with congestive heart failure. Mayo Clin Proc 1992;67:719-24.
31. Stewart DJ, Kubag G, Costello KB, et al. Increased plasma endothelin-1 in early hours of acute myocardial infarction. J Am Coll Cardiol 1991;18:38-43.
32. Takahashi K, Ghatei MA, Lam H-C, et al. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990;33:306-10.
33. Letizia C, Iannaccone A, Cerci S, et al. Circulating endothelin-1 in non-insulin-dependent diabetic patients with retinopathy. Horm Metab Res 1997;29:247-51.
34. Matsui Y, Katsumi O, Mehta MC, et al. Correlation of electroretinographic and fluorescein angiographic findings in unilateral central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1994;232:449-57.
35. The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993;116:286-96.
36. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458-74.
37. The Central Vein Occlusion Study Group. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-95.
38. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545-54.
39. Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
40. Wagner O, Novotny P, Vierhapper H, et al. Plasma concentrations of endothelin in man: arterio-venous differences and release during venous stasis. Eur J Clin Invest 1990;20: 502-5.
41. Metsarinne K, Nordström D, Santavirta S, et al. Effect of prolonged tourniquet ischaemia and short-term venous stasis on plasma endothelin-1 levels in man. Scand J Clin Lab Invest 1995;55:251-6.
42. Khono M, Yasunari K, Yokokawa K, et al. Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells. Metabolism 1990;39:1003-5.
43. Marsen TA, Simonson MS, Dunn MJ. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circulation Res 1995;76:987-95.
44. Rakugi H, Tubuchi Y, Nakamuri M, et al. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 1990;169:973-7.
45. Kourembanas S, Marsden PA, McQuillan LP, et al. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-7.
46. Gertler JP, Ocasio VH. Endothelin production by hypoxic human endothelium. J Vascular Surg 1993;18:178-82
47. Li H, Chen S-J, Chen Y-F, et al. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 1994;77:1451-9.
48. Donati G, Pournaras CJ, Pizzolato GP, et al. Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci 1997;38:1450-7.
49. Pola P, Tondi P, Favuzzi A, et al. Treatment of retinal vein thrombosis with defibrotide. Curr Ther Res 1993;53: 340-6.
50. Berti F, Rossoni G, Ferro L, et al. Defibrotide, via prostacyclin release, antagonizes endothelin-1 induced vasospasm in rabbit and human coronary artery. Intern Med 1994;2:49-56.